Actinium Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $81 | $0 |
Gross Profit | -189 | -216 | -118 | -200 |
EBITDA | -12,229 | -9,381 | -10,144 | -14,151 |
EBIT | -12,418 | -9,597 | -10,343 | -14,351 |
Net Income | -11,353 | -8,670 | -9,324 | -13,276 |
Net Change In Cash | 0 | 0 | 81 | 0 |
Free Cash Flow | -7,972 | -7,385 | -7,490 | -11,155 |
Cash | 86,037 | 84,057 | 76,677 | 82,978 |
Basic Shares | 30,103 | 27,886 | 27,634 | 27,058 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $81 | $1,030 | $1,144 | $622 |
Gross Profit | -709 | 331 | 620 | -447 |
EBITDA | -51,130 | -33,405 | -24,440 | -21,946 |
EBIT | -51,920 | -34,104 | -24,964 | -22,393 |
Net Income | -48,818 | -31,930 | -24,584 | -22,037 |
Net Change In Cash | 81 | 1,030 | 1,144 | 622 |
Cost of Revenue | 14,222 | 54,306 | ||
Free Cash Flow | -47,488 | 8,278 | -20,999 | -21,870 |
Cash | 76,677 | 108,910 | 77,829 | 63,560 |
Basic Shares | 26,604 | 24,141 | 20,568 | 12,134 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.38 |
2024-03-31 | -$0.31 |
2023-12-31 | -$0.34 |
2023-09-30 | -$0.49 |
